Organisation: Eli Lilly & Co

A COMPREHENSIVE SERIES OF ARTICLES ON THIS TOPIC

<p>For now, Novo Nordisk’s Ozempic and Wegovy and Eli Lilly’s Zepbound are the leading therapies in a weight-loss market that could grow to $100bn (€92bn) by 2030, according to Goldman Sachs estimates.</p>

companies

Weight loss drugmakers race to make muscle retention treatments

Preserving muscle is an alluring goal for drugmakers that missed the first generation of obesity treatments and are seeking a foothold in the fast-growing and lucrative field

property

Quality cottage in Cork’s Dunderrow worth viewing post haste...

business

Suspension of Zilmax sales prompts shortage of rival cattle feed additive

business

J&J gets diabetes drug go-ahead

business

Net profits fall 27% at Eli Lilly

business

US stocks tumble

Probe as Viagra use linked to blindness

US HEALTH officials are examining 38 reports of blindness among some men using Viagra.

Sat, 28 May, 2005

Plan to legalise medicines’ import

Republican and Democratic US senators have introduced legislation that would make it legal for Americans to import prescription drugs from licensed pharmacies in Canada and other countries.

Fri, 23 Apr, 2004

Viagra loyalty scheme by Pfizer

PFIZER is introducing a buy-six Viagra get-one-free sales pitch as the innovative impotence drug faces up to strong competition from new rivals Levitra and Cialis.

Thu, 15 Apr, 2004

Galen shares rise by 3.81%

SHARES in Galen Holdings increased by 3.81% yesterday after the company announced better-than-expected results in its final quarter.

Wed, 12 Nov, 2003

Banks lead market higher

THE ISEQ Index of shares closed marginally higher yesterday, gaining 13.28 to 4179.92 points.

Wed, 11 Dec, 2002